Gerold Bepler, M.D., Ph.D., president and CEO of the Barbara Ann Karmanos Cancer Institute, has been elected to serve a three-year term on the Association of American Cancer Institutes (AACI) Board of Directors, effective October 15.
AACI comprises 97 leading cancer research centers in North America and is dedicated to reducing the burden of cancer by enhancing the impact of these leading academic cancer centers.
“I am honored and pleased to be elected to the AACI Board of Directors that represents elite cancer centers across the country,” Dr. Bepler said. “I look forward to collaborating with fellow board members to help cancer experts advance this nation’s cancer care.”
In addition to leading the Karmanos Cancer Institute headquartered in Detroit, Dr. Bepler is a world-renowned thoracic oncologist who has spent his career researching risks, progression, treatments and outcomes related to lung cancer, with a special focus on non-small cell lung cancer.